| Fatty acid transport protein 2 reprograms neutrophils in cancer F Veglia, VA Tyurin, M Blasi, A De Leo, AV Kossenkov, L Donthireddy, ... Nature 569 (7754), 73-78, 2019 | 475 | 2019 |
| Selective inhibition of protein arginine methyltransferase 5 blocks initiation and maintenance of B-cell transformation L Alinari, KV Mahasenan, F Yan, V Karkhanis, JH Chung, EM Smith, ... Blood, The Journal of the American Society of Hematology 125 (16), 2530-2543, 2015 | 162 | 2015 |
| Analysis of classical neutrophils and polymorphonuclear myeloid-derived suppressor cells in cancer patients and tumor-bearing mice F Veglia, A Hashimoto, H Dweep, E Sanseviero, A De Leo, E Tcyganov, ... Journal of Experimental Medicine 218 (4), 2021 | 155 | 2021 |
| Myeloid cells in glioblastoma microenvironment A De Leo, A Ugolini, F Veglia Cells 10 (1), 18, 2020 | 101 | 2020 |
| Resveratrol inhibits Epstein Barr Virus lytic cycle in Burkitt’s lymphoma cells by affecting multiple molecular targets A De Leo, G Arena, E Lacanna, G Oliviero, F Colavita, E Mattia Antiviral research 96 (2), 196-202, 2012 | 79 | 2012 |
| Identification of MEF2B, EBF1, and IL6R as Direct Gene Targets of Epstein-Barr Virus (EBV) Nuclear Antigen 1 Critical for EBV-Infected B-Lymphocyte Survival I Tempera, A De Leo, AV Kossenkov, M Cesaroni, H Song, N Dawany, ... Journal of virology 90 (1), 345-355, 2016 | 73 | 2016 |
| Control of viral latency by episome maintenance proteins A De Leo, A Calderon, PM Lieberman Trends in microbiology 28 (2), 150-162, 2020 | 72 | 2020 |
| Epigenetic specifications of host chromosome docking sites for latent Epstein-Barr virus KD Kim, H Tanizawa, A De Leo, O Vladimirova, A Kossenkov, F Lu, ... Nature communications 11 (1), 877, 2020 | 56 | 2020 |
| Resveratrol inhibits rhinovirus replication and expression of inflammatory mediators in nasal epithelia P Mastromarino, D Capobianco, F Cannata, C Nardis, E Mattia, A De Leo, ... Antiviral research 123, 15-21, 2015 | 56 | 2015 |
| Inhibition of autophagy in EBV-positive Burkitt’s lymphoma cells enhances EBV lytic genes expression and replication A De Leo, F Colavita, F Ciccosanti, GM Fimia, PM Lieberman, E Mattia Cell Death and Disease, 2015 | 50 | 2015 |
| Resveratrol Inhibits Proliferation and Survival of Epstein Barr Virus–Infected Burkitt's Lymphoma Cells Depending on Viral Latency Program A De Leo, G Arena, C Stecca, M Raciti, E Mattia Molecular Cancer Research 9 (10), 1346-1355, 2011 | 46 | 2011 |
| Inhibition of p38 MAP kinase pathway induces apoptosis and prevents Epstein Barr virus reactivation in Raji cells exposed to lytic cycle inducing compounds G Matusali, G Arena, A De Leo, L Di Renzo, E Mattia Molecular cancer 8, 1-11, 2009 | 44 | 2009 |
| BET-inhibitors disrupt Rad21-dependent conformational control of KSHV latency HS Chen, A De Leo, Z Wang, A Kerekovic, R Hills, PM Lieberman PLoS pathogens 13 (1), e1006100, 2017 | 38 | 2017 |
| LANA oligomeric architecture is essential for KSHV nuclear body formation and viral genome maintenance during latency A De Leo, Z Deng, O Vladimirova, HS Chen, J Dheekollu, A Calderon, ... PLoS Pathogens 15 (1), e1007489, 2019 | 32 | 2019 |
| Deregulation of KSHV latency conformation by ER-stress and caspase-dependent RAD21-cleavage A De Leo, HS Chen, CCA Hu, PM Lieberman PLoS pathogens 13 (8), e1006596, 2017 | 30 | 2017 |
| Phase separation and DAXX redistribution contribute to LANA nuclear body and KSHV genome dynamics during latency and reactivation O Vladimirova, A De Leo, Z Deng, A Wiedmer, J Hayden, PM Lieberman PLoS pathogens 17 (1), e1009231, 2021 | 26 | 2021 |
| Identification of Mubritinib (TAK 165) as an inhibitor of KSHV driven primary effusion lymphoma via disruption of mitochondrial OXPHOS metabolism A Calderon, SS Soldan, A De Leo, Z Deng, DM Frase, EM Anderson, ... Oncotarget 11 (46), 4224, 2020 | 12 | 2020 |
| Defective Epstein-Barr virus genomes and atypical viral gene expression in B-cell lines derived from multiple myeloma patients F Lu, KA Martin, SS Soldan, AV Kossenkov, P Wickramasinghe, ... Journal of Virology 95 (13), 10.1128/jvi. 00088-21, 2021 | 7 | 2021 |
| Down-regulation of proteolytic complexes following EBV activation in BL cells G Matusali, A De Leo, R Gavioli, L Bertelli, L Di Renzo, E Mattia Biochemical and biophysical research communications 352 (4), 947-952, 2007 | 4 | 2007 |
Filippo VegliaAssistant Member in ImmunologyEmail verificata su moffitt.org
